Bulletin
Investor Alert

Thermo Fisher Scientific Inc.

NYS: TMO

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jul 10, 2020, 5:39 p.m.

TMO
/zigman2/quotes/201150432/composite

$

382.65

Change

+0.08 +0.02%

Volume

Volume 51,863

Quotes are delayed by 20 min

/zigman2/quotes/201150432/composite

Previous close

$ 387.67

$ 382.57

Change

-5.10 -1.32%

Day low

Day high

$381.74

$391.58

Open

52 week low

52 week high

$250.21

$395.00

Open

Company Description

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Dia...

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Valuation

P/E Current

42.27

P/E Ratio (with extraordinary items)

42.26

P/E Ratio (without extraordinary items)

35.42

Price to Sales Ratio

5.13

Price to Book Ratio

4.37

Price to Cash Flow Ratio

26.33

Enterprise Value to EBITDA

22.38

Enterprise Value to Sales

5.75

Total Debt to Enterprise Value

0.13

Efficiency

Revenue/Employee

340,560.00

Income Per Employee

49,280.00

Receivables Turnover

5.35

Total Asset Turnover

0.45

Liquidity

Current Ratio

1.92

Quick Ratio

1.38

Cash Ratio

0.39

Profitability

Gross Margin

44.41

Operating Margin

16.67

Pretax Margin

15.93

Net Margin

14.47

Return on Assets

6.45

Return on Equity

12.91

Return on Total Capital

8.99

Return on Invested Capital

7.98

Capital Structure

Total Debt to Total Equity

62.31

Total Debt to Total Capital

38.39

Total Debt to Total Assets

31.67

Long-Term Debt to Equity

59.47

Long-Term Debt to Total Capital

36.64

Officers and Executives

Name Age Officer Since Title
Mr. Marc N. Casper 51 2001 Chief Operating Officer & Executive Vice President
Mr. Stephen Williamson 52 2001 Vice President-Financial Operations
Mr. Ryan Snyder - 2019 Chief Information Officer & Senior Vice President
Ms. Amy Butler - - Vice President
Ms. Pascale Thomas - - Vice President-Global Benefits & Mobility

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
07/02/2020 Michael A. Boxer
Sr. VP and Gen. Counsel
176   Derivative/Non-derivative trans. at $365.89 per share. 64,396
06/02/2020 Marc N. Casper
Chairman & CEO; Director
34,500   Gift at $0 per share. 0
06/02/2020 Marc N. Casper
Chairman & CEO; Director
14,795   Derivative/Non-derivative trans. at $124.28 per share. 1,838,722
06/02/2020 Marc N. Casper
Chairman & CEO; Director
34,500   Gift at $0 per share. 0
06/02/2020 Marc N. Casper
Chairman & CEO; Director
817   Disposition at $350.08 per share. 286,015
06/02/2020 Marc N. Casper
Chairman & CEO; Director
13,978   Disposition at $349.52 per share. 4,885,590
06/01/2020 Marc N. Casper
Chairman & CEO; Director
7,587   Disposition at $350.37 per share. 2,658,257
06/01/2020 Marc N. Casper
Chairman & CEO; Director
12,413   Disposition at $349.59 per share. 4,339,460
06/01/2020 Stephen Williamson
Sr. VP and CFO
2,500   Disposition at $348 per share. 870,000
06/01/2020 Marc N. Casper
Chairman & CEO; Director
20,000   Derivative/Non-derivative trans. at $124.28 per share. 2,485,600
05/29/2020 Marc N. Casper
Chairman & CEO; Director
20,000   Disposition at $349.26 per share. 6,985,200
05/29/2020 Marc N. Casper
Chairman & CEO; Director
20,000   Derivative/Non-derivative trans. at $124.28 per share. 2,485,600
05/20/2020 Scott M. Sperling
Director
572   Award at $0 per share. 0
05/20/2020 Jim P. Manzi
Director
572   Award at $0 per share. 0
05/20/2020 Judy Carol Lewent
Director
572   Award at $0 per share. 0
05/20/2020 Thomas J. Lynch
Director
572   Award at $0 per share. 0
05/20/2020 Nelson J. Chai
Director
572   Award at $0 per share. 0
05/20/2020 Lars Rebien Sørensen
Director
572   Award at $0 per share. 0
05/20/2020 Tyler Jacks
Director
572   Award at $0 per share. 0
05/20/2020 C. Martin Harris
Director
572   Award at $0 per share. 0
05/20/2020 Ingrid Freire
Director
572   Award at $0 per share. 0
05/20/2020 James C. Mullen
Director
572   Award at $0 per share. 0
05/20/2020 Debora L. Spar
Director
572   Award at $0 per share. 0
05/20/2020 Lars Rebien Sørensen
Director
216   Derivative/Non-derivative trans. at $341.15 per share. 73,688
05/18/2020 Marc N. Casper
Chairman & CEO; Director
100   Disposition at $351.18 per share. 35,118
05/18/2020 Marc N. Casper
Chairman & CEO; Director
1,754   Disposition at $350.57 per share. 614,899
05/18/2020 Marc N. Casper
Chairman & CEO; Director
14,851   Disposition at $349.3 per share. 5,187,454
05/18/2020 Mark P. Stevenson
Executive Vice President & COO
748   Disposition at $351.03 per share. 262,570
05/18/2020 Mark P. Stevenson
Executive Vice President & COO
3,151   Disposition at $350.16 per share. 1,103,354
05/18/2020 Mark P. Stevenson
Executive Vice President & COO
8,249   Disposition at $349.16 per share. 2,880,220
05/18/2020 Mark P. Stevenson
Executive Vice President & COO
9,870   Disposition at $348.3 per share. 3,437,721
05/18/2020 Mark P. Stevenson
Executive Vice President & COO
2,982   Disposition at $347.32 per share. 1,035,708
05/18/2020 Marc N. Casper
Chairman & CEO; Director
16,705   Derivative/Non-derivative trans. at $124.28 per share. 2,076,097
05/18/2020 Mark P. Stevenson
Executive Vice President & COO
25,000   Derivative/Non-derivative trans. at $124.28 per share. 3,107,000
04/28/2020 Marc N. Casper
Chairman & CEO; Director
300   Disposition at $343.72 per share. 103,116
04/28/2020 Marc N. Casper
Chairman & CEO; Director
400   Disposition at $341.77 per share. 136,708
04/28/2020 Marc N. Casper
Chairman & CEO; Director
800   Disposition at $341.03 per share. 272,824
04/28/2020 Marc N. Casper
Chairman & CEO; Director
100   Disposition at $338.88 per share. 33,888
04/28/2020 Marc N. Casper
Chairman & CEO; Director
600   Disposition at $337.43 per share. 202,458
04/28/2020 Marc N. Casper
Chairman & CEO; Director
772   Disposition at $336.36 per share. 259,669
04/28/2020 Marc N. Casper
Chairman & CEO; Director
300   Disposition at $335.07 per share. 100,521
04/28/2020 Marc N. Casper
Chairman & CEO; Director
3,045   Disposition at $334.2 per share. 1,017,639
04/28/2020 Marc N. Casper
Chairman & CEO; Director
8,358   Disposition at $333.16 per share. 2,784,551
04/28/2020 Marc N. Casper
Chairman & CEO; Director
8,072   Disposition at $332.21 per share. 2,681,599
04/28/2020 Marc N. Casper
Chairman & CEO; Director
3,344   Disposition at $331.19 per share. 1,107,499
04/28/2020 Marc N. Casper
Chairman & CEO; Director
3,100   Disposition at $330.33 per share. 1,024,023
04/28/2020 Marc N. Casper
Chairman & CEO; Director
809   Disposition at $328.94 per share. 266,112
04/28/2020 Marc N. Casper
Chairman & CEO; Director
30,000   Derivative/Non-derivative trans. at $124.28 per share. 3,728,400
04/24/2020 Mark P. Stevenson
Executive Vice President & COO
13,509   Disposition at $328.73 per share. 4,440,813
04/24/2020 Mark P. Stevenson
Executive Vice President & COO
7,468   Disposition at $327.85 per share. 2,448,383
04/24/2020 Mark P. Stevenson
Executive Vice President & COO
1,690   Disposition at $326.88 per share. 552,427
04/24/2020 Mark P. Stevenson
Executive Vice President & COO
1,533   Disposition at $325.76 per share. 499,390
04/24/2020 Mark P. Stevenson
Executive Vice President & COO
800   Disposition at $324.55 per share. 259,640
04/24/2020 Mark P. Stevenson
Executive Vice President & COO
25,000   Derivative/Non-derivative trans. at $124.28 per share. 3,107,000
03/23/2020 Michel Lagarde
Executive Vice President
1,256   Derivative/Non-derivative trans. at $278.37 per share. 349,632
03/07/2020 Michel Lagarde
Executive Vice President
945   Derivative/Non-derivative trans. at $311.17 per share. 294,055
/news/latest/company/us/tmo

MarketWatch News on TMO

  1. Barron’s 2020 Midyear Roundtable: 37 Picks From Our Investment Pros

    11 min ago

    - Barron's Online

  2. Here Are a Few Sectors and Three Dozen Stocks for a Blue Wave

    1:30 p.m. July 7, 2020

    - Barron's Online

  3. Fauci Says Vaccine Could Be Ready by Early 2021

    5:00 p.m. June 23, 2020

    - Barron's Online

  4. Amazon is Now a Low-Volatility Stock

    9:46 a.m. May 24, 2020

    - Barron's Online

  5. Health-Care Stocks Popular With ESG Funds Outperform

    9:15 a.m. May 16, 2020

    - Barron's Online

  6. Thermo Fisher profit and revenue rise above expectations

    6:15 a.m. April 22, 2020

    - Tomi Kilgore

  7. Thermo Fisher Q1 EPS $1.97 vs. $2.02 a year ago

    6:05 a.m. April 22, 2020

    - Tomi Kilgore

  8. Thermo Fisher Q1 adj. EPS $2.94; FactSet consensus $2.80

    6:05 a.m. April 22, 2020

    - Tomi Kilgore

  9. Ford Teams Up With 3M, Thermo Fisher on Health Equipment

    3:46 p.m. April 13, 2020

    - Barron's Online

  10. Thermo Fisher sees Q1 revenue growth 1%-2%; FactSet consensus $6.14 bln implies 0.2% growth

    8:39 a.m. April 6, 2020

    - Tomi Kilgore

  11. Abbott Stock Soars on News of 5-Minute Test for Covid-19

    3:10 p.m. March 30, 2020

    - Barron's Online

  12. Time Out shares fall after warning over virus hit

    4:21 a.m. March 23, 2020

    - MarketWatch.com

  13. A New Deal for Health Care

    8:31 p.m. March 22, 2020

    - Barron's Online

  14. Loading more headlines...
/news/nonmarketwatch/company/us/tmo

Other News on TMO

  1. Thermo Fisher bid for Qiagen inadequate - Davidson Kempner

    12:11 p.m. July 10, 2020

    - Seeking Alpha

  2. Top Research Reports for Apple, Microsoft & TMobile

    12:30 p.m. July 9, 2020

    - Zacks.com

  3. Outlook for Diagnostics Sector Tests Positive

    11:26 a.m. July 7, 2020

    - Charley Grant

  4. Thermo Fisher Stock Rises on Solid Q2 Growth Expectation

    10:21 a.m. July 7, 2020

    - Zacks.com

  5. 7 Healthcare ETFs Which Should Continue Growing Into 2021

    1:56 p.m. July 6, 2020

    - InvestorPlace.com

  6. Thermo Fisher leads rally in life science toolmakers

    10:25 a.m. July 6, 2020

    - Seeking Alpha

  7. Becton, Dickinson launches COVID-19 rapid test in U.S.

    9:52 a.m. July 6, 2020

    - Seeking Alpha

  8. Top 10 Healthcare Stocks For Dividend Growth And Income

    9:01 a.m. July 6, 2020

    - Seeking Alpha

  9. Thermo Fisher sees better than forecast 2Q revenue

    8:23 a.m. July 6, 2020

    - Seeking Alpha

  10. 2020 First Half Portfolio Review

    4:15 p.m. July 5, 2020

    - Seeking Alpha

  11. Carter Worth's Picks For The Second Half Of 2020

    1:37 p.m. July 1, 2020

    - Benzinga.com

  12. Best ETFs for 2020: The AdvisorShares Vice ETF Bets Big on Booze

    11:09 a.m. July 1, 2020

    - InvestorPlace.com

  13. Loading more headlines...

At a Glance

Thermo Fisher Scientific, Inc.

168 Third Avenue

Waltham, Massachusetts 02451

Phone

1 7816221000

Industry

Medical Equipment/Supplies

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2020

Revenue

$25.54B

Net Income

$3.70B

2019 Sales Growth

4.9%

Employees

75,000

/news/pressrelease/company/us/tmo

Press Releases on TMO

  1. Daily Dividend Report: COO,PAYX,TMO,LNT,AIZ

    12:10 p.m. July 10, 2020

    - MarketNewsVideo.com

  2. Thermo Fisher Scientific Declares Quarterly Dividend

    5:00 p.m. July 9, 2020

    - PR Newswire - PRF

  3. Bullish US Stocks Surging Above Parabolic SAR: $SAP $TMO $UL

    3:12 p.m. June 29, 2020

    - The Market Signal

  4. Loading more headlines...
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.